tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vincent Chen, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).
Analyst Vincent Chen works with a stock forecast success ratio of 66.67% fulfilled within 227.5 days on average. Previously, Vincent Chen worked at BERNSTEIN.
Vincent Chen’s has documented 21 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 23-Mar-2021.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 2/20/2018. The price target of $55 was fulfilled within 21 days with a profit of $5.01 (10.02%) receiving and performance score of 4.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
63
$20.55 (48.41%)
62
2 months 3 days ago
11/24 (45.83%)
$19.02 (43.25%)
270
Buy
60
$17.55 (41.34%)
60
2 months 3 days ago
0/8 (0%)
$16.02 (36.43%)
Hold
55
$12.55 (29.56%)
41
2 months 24 days ago
2/3 (66.67%)
$4.03 (7.91%)
79
Buy
70
$27.55 (64.90%)
65
2 months 30 days ago
0/8 (0%)
$18.51 (35.95%)
Hold
48
$5.55 (13.07%)
27
3 months 3 days ago
7/12 (58.33%)
$-3.01 (-5.90%)
95
What Year was the first public recommendation made by Vincent Chen?
